Advanced Biomed Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Advanced Biomed Inc. now
Current reporting with the operating signal separated from the noise.
Advanced Biomed Inc.
The story matters when it changes Advanced Biomed Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
The story matters when it changes Advanced Biomed Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
The development tests whether Advanced Biomed Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Advanced Biomed Inc. Announces Pricing of Initial Public Offering
The story matters when it changes Advanced Biomed Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ADVB filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Advanced Biomed Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →